Search

Meryl Mendelson Phones & Addresses

  • 21 Fenbrook Dr, Larchmont, NY 10538 (914) 833-9363
  • Scarsdale, NY
  • Brooklyn, NY
  • Atlantic Beach, NY
  • New York, NY

Work

Company: Novartis Jul 2011 Address: East Hanover, New Jersey Position: Executive medical director, infectious diseases

Education

School / High School: Albany Medical College 1978

Skills

Asthma • Cro • Clinical Development • Clinical Trials • Drug Development • Gcp • Infectious Diseases • Internal Medicine • Medical Affairs • Medical Writing • Medicine • Pharmaceutical Industry • Therapeutic Areas • Biotechnology • Cro Management • Life Sciences • Good Clinical Practice

Languages

English • Spanish

Awards

Healthgrades Honor Roll

Ranks

Certificate: Infectious Disease, 1984

Industries

Pharmaceuticals

Specialities

Infectious Disease Medicine

Professional Records

Medicine Doctors

Meryl Mendelson Photo 1

Dr. Meryl Mendelson, Larchmont NY - MD (Doctor of Medicine)

View page
Specialties:
Infectious Disease Medicine
Address:
21 Fenbrook Dr, Larchmont, NY 10538
(914) 833-9363 (Phone)
Certifications:
Infectious Disease, 1984
Internal Medicine, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Spanish
Education:
Medical School
Albany Medical College
Graduated: 1978
Medical School
Mt Sinai Med Center
Graduated: 1978
Meryl Mendelson Photo 2

Meryl H Mendelson

View page
Specialties:
Internal Medicine
Infectious Disease
Education:
Albany Medical College (1978)
Meryl Mendelson Photo 3

Meryl H Mendelson, New York NY

View page
Specialties:
Infectious Disease Specialist
Address:
1 Gustave L Levy Pl, New York, NY 10029
Education:
Albany Medical College - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)

Resumes

Resumes

Meryl Mendelson Photo 4

Senior Global Program Head, Immunology

View page
Location:
21 Fenbrook Dr, Larchmont, NY 10538
Industry:
Pharmaceuticals
Work:
Novartis - East Hanover, New Jersey since Jul 2011
Executive Medical Director, Infectious Diseases

Novartis Pharmaceuticals Corporation Apr 2007 - Jul 2011
Executive Director, Global Program Medical Director

Pfizer Pharmaceuticals 2006 - 2007
Senior Medical Director

Pfizer Pharmaceuticals 2004 - 2006
Medical Director

Bayer HealthCare 2003 - 2004
Associate Medical Director
Education:
Albany Medical College of Union University
MD
Rensselaer Polytechnic Institute
BS, Biology
Skills:
Asthma
Cro
Clinical Development
Clinical Trials
Drug Development
Gcp
Infectious Diseases
Internal Medicine
Medical Affairs
Medical Writing
Medicine
Pharmaceutical Industry
Therapeutic Areas
Biotechnology
Cro Management
Life Sciences
Good Clinical Practice
Certifications:
Internal Medicine
Infectious Diseases
American Board of Internal Medicine

Business Records

Name / Title
Company / Classification
Phones & Addresses
Meryl Mendelson
Medical Doctor
Radiology Associates
Medical Doctor's Office
1176 5 Ave, New York, NY 10029
(212) 241-8333
Meryl H. Mendelson
Meryl Mendelson MD
Internist
21 Fenbrook Dr, Larchmont, NY 10538
(914) 833-9363

Publications

Us Patents

Methods Of Treating Autoimmune Diseases Using Interleukin-17 (Il-17) Antagonists

View page
US Patent:
20220363749, Nov 17, 2022
Filed:
Sep 18, 2020
Appl. No.:
17/761485
Inventors:
- Basel, CH
Thomas DUMORTIER - Basel, CH
Meryl MENDELSON - Larchmont NY, US
Shephard MPOFU - Oberwil, CH
Luminita PRICOP - New York NY, US
International Classification:
C07K 16/24
A61P 19/02
A61K 38/13
A61K 31/4706
A61K 31/519
A61K 31/4402
A61K 31/42
A61K 31/573
A61K 39/395
Abstract:
The present disclosure relates to methods for treating patients having autoimmune diseases, e.g., methods for treating psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), e.g., non-radiographic axial spondyloarthritis (nr-axSpA) or ankylosing spondylitis (AS), using IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab. Also disclosed herein are methods for inhibiting the progression of structural damage in PsA and axSpA patients using IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab. The present disclosure also provides medicaments, pharmaceutical formulations, dosage forms, and kits for use in the disclosed methods.
Meryl H Mendelson from Larchmont, NY, age ~69 Get Report